• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低级别子宫内膜间质肉瘤保留生育功能手术后的复发情况。

Recurrence after fertility-preserving surgery for low-grade endometrial stromal sarcoma.

作者信息

Chin Tzu-Hsuan, Lin Gigin, Wu Ren-Chin, Lai Chyong-Huey

机构信息

Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.

Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

J Obstet Gynaecol Res. 2018 Sep;44(9):1836-1842. doi: 10.1111/jog.13695. Epub 2018 Jul 5.

DOI:10.1111/jog.13695
PMID:29974555
Abstract

Considering the characteristics of low-grade endometrial stromal sarcoma (ESS), such as relative indolent course, younger age at diagnosis and favorable prognosis, the fertility-preserving management of low-grade ESS has been described by several authors. We report a 34-year-old female with stage IB low-grade ESS who developed recurrence 7 years after neoadjuvant high-dose progestin therapy followed by fertility-preserving surgery and postoperative progestin therapy. The patient stopped progestin therapy and was disease free for 4 years after diagnosis but experienced recurrence with peritoneal dissemination at 7 years. Considering the tendency of late recurrence, long-term surveillance is necessary to ensure timely action. Long-term progestin treatment might be considered after complete remission even beyond 5 years. We performed a literature review and found that many of the cases did not meet solid pathological criteria of low-grade ESS. The diagnostic criteria of low-grade ESS (vs endometrial stromal nodule) should be deliberately documented for future studies of this rare disease.

摘要

考虑到低级别子宫内膜间质肉瘤(ESS)的特点,如病程相对惰性、诊断时年龄较轻以及预后良好,已有多位作者描述了低级别ESS的保留生育功能管理。我们报告了一名34岁患有IB期低级别ESS的女性,她在新辅助大剂量孕激素治疗后接受了保留生育功能手术及术后孕激素治疗,7年后出现复发。该患者在诊断后停止了孕激素治疗,4年无病,但在7年时出现腹膜播散复发。考虑到晚期复发的趋势,有必要进行长期监测以确保及时采取行动。即使在完全缓解超过5年后,也可考虑长期孕激素治疗。我们进行了文献综述,发现许多病例不符合低级别ESS的可靠病理标准。对于这种罕见疾病的未来研究,应谨慎记录低级别ESS(与子宫内膜间质结节相比)的诊断标准。

相似文献

1
Recurrence after fertility-preserving surgery for low-grade endometrial stromal sarcoma.低级别子宫内膜间质肉瘤保留生育功能手术后的复发情况。
J Obstet Gynaecol Res. 2018 Sep;44(9):1836-1842. doi: 10.1111/jog.13695. Epub 2018 Jul 5.
2
Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma?卵巢保留术对早期低级别子宫内膜间质肉瘤的复发有影响吗?
J Obstet Gynaecol. 2021 Jul;41(5):797-802. doi: 10.1080/01443615.2020.1803238. Epub 2020 Oct 16.
3
Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report.芳香酶抑制剂阿那曲唑作为复发性低级别子宫内膜间质肉瘤的二线激素治疗:一例报告。
Med Oncol. 2011 Sep;28(3):771-4. doi: 10.1007/s12032-010-9511-6. Epub 2010 Mar 31.
4
Endometrial stromal sarcoma: a rare entity.子宫内膜间质肉瘤:一种罕见的疾病。
J Coll Physicians Surg Pak. 2015 Mar;25(3):216-7.
5
Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma.低级别子宫内膜间质肉瘤患者的保留生育功能手术
Oncotarget. 2017 Feb 7;8(6):10602-10608. doi: 10.18632/oncotarget.12491.
6
Treatment of recurrent or metastatic low-grade endometrial stromal sarcoma: three case reports.复发性或转移性低度子宫内膜间质肉瘤的治疗:三例报告。
Int J Gynecol Cancer. 2010 Oct;20(7):1197-200. doi: 10.1111/igc.0b013e3181ef6d87.
7
Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?世界卫生组织 2003 年定义的 I 期至 II 期低级别子宫内膜间质肉瘤:需要多少初始治疗,多少又足够?
Int J Gynecol Cancer. 2013 Mar;23(3):488-93. doi: 10.1097/IGC.0b013e318247aa14.
8
[Analysis of prognosis and pregnancy outcomes of fertility-preserving treatment for patients with stage Ⅰa, grade 2 endometrial cancer].[Ⅰa期2级子宫内膜癌患者保留生育功能治疗的预后及妊娠结局分析]
Zhonghua Fu Chan Ke Za Zhi. 2020 May 25;55(5):327-332. doi: 10.3760/cma.j.cn112141-20200118-00047.
9
Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review.低级别子宫内膜间质肉瘤中卵巢切除术和激素抑制的影响:一项多中心回顾。
Gynecol Oncol. 2018 May;149(2):297-300. doi: 10.1016/j.ygyno.2018.03.008. Epub 2018 Mar 11.
10
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.激素治疗对转移性低级别子宫内膜间质肉瘤的危害或益处:单中心10例经验及文献综述
Gynecol Oncol. 2006 Jun;101(3):464-9. doi: 10.1016/j.ygyno.2005.11.010. Epub 2005 Dec 20.

引用本文的文献

1
Reproductive and oncologic outcomes in young women with uterine sarcoma undergoing fertility-sparing treatment: a systematic review.接受保留生育功能治疗的子宫肉瘤年轻女性的生殖和肿瘤学结局:一项系统评价
Ther Adv Reprod Health. 2024 Sep 23;18:26334941241271563. doi: 10.1177/26334941241271563. eCollection 2024 Jan-Dec.
2
Fertility-Sparing Management May Be Considered in Young Women with Uterine Sarcoma.子宫肉瘤的年轻女性可考虑保留生育功能的管理。
J Clin Med. 2022 Aug 15;11(16):4761. doi: 10.3390/jcm11164761.
3
Uterine Preservation Treatments in Sarcomas: Oncological Problems and Reproductive Results: A Systematic Review.
子宫肉瘤的保留子宫治疗:肿瘤学问题与生殖结局:一项系统综述
Cancers (Basel). 2021 Nov 19;13(22):5808. doi: 10.3390/cancers13225808.
4
Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series, a population-based analysis and review of the literature.低级别子宫内膜间质肉瘤的保留生育功能管理:一项机构队列分析、基于人群的分析及文献综述
Ann Transl Med. 2020 Nov;8(21):1358. doi: 10.21037/atm-20-2180.